AdAlta Limited (1AD.AX)
AUD 0.02
(-6.25%)
AUD 0.02
(-6.25%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 1.5 Million AUD | -56.16% |
| 2023 | 3.43 Million AUD | 37.96% |
| 2022 | 2.49 Million AUD | -34.1% |
| 2021 | 3.78 Million AUD | 3.44% |
| 2020 | 3.65 Million AUD | 4.31% |
| 2019 | 3.5 Million AUD | 73.83% |
| 2018 | 2.01 Million AUD | 12.6% |
| 2017 | 1.79 Million AUD | 142.94% |
| 2016 | 737.36 Thousand AUD | 181.21% |
| 2015 | -907.99 Thousand AUD | -4.92% |
| 2014 | -865.41 Thousand AUD | -121.82% |
| 2013 | -390.14 Thousand AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | -62.96 Thousand AUD | -101.83% |
| 2024 Q4 | 485.48 Thousand AUD | 0.0% |
| 2024 Q2 | 1.12 Million AUD | 0.0% |
| 2023 Q4 | 2.34 Million AUD | 0.0% |
| 2023 FY | 3.43 Million AUD | 37.96% |
| 2023 Q2 | 1.09 Million AUD | 0.0% |
| 2022 Q4 | 1.86 Million AUD | 0.0% |
| 2022 Q2 | 633.49 Thousand AUD | 0.0% |
| 2022 FY | 2.49 Million AUD | -34.1% |
| 2021 Q4 | 68.43 Thousand AUD | 0.0% |
| 2021 Q2 | 761.2 Thousand AUD | 0.0% |
| 2021 FY | 3.78 Million AUD | 3.44% |
| 2020 Q2 | 404.23 Thousand AUD | 0.0% |
| 2020 Q4 | 59.01 Thousand AUD | 0.0% |
| 2020 FY | 3.65 Million AUD | 4.31% |
| 2019 FY | 3.5 Million AUD | 73.83% |
| 2019 Q2 | 34.87 Thousand AUD | 0.0% |
| 2019 Q4 | -4.03 Million AUD | 0.0% |
| 2018 Q4 | -2.17 Million AUD | 0.0% |
| 2018 Q2 | 37.92 Thousand AUD | 0.0% |
| 2018 FY | 2.01 Million AUD | 12.6% |
| 2017 Q2 | 32.46 Thousand AUD | 0.0% |
| 2017 FY | 1.79 Million AUD | 142.94% |
| 2017 Q4 | -1.9 Million AUD | 0.0% |
| 2016 Q1 | 2404.00 AUD | 0.0% |
| 2016 Q4 | -725.29 Thousand AUD | 0.0% |
| 2016 Q2 | 4807.00 AUD | 99.96% |
| 2016 FY | 737.36 Thousand AUD | 181.21% |
| 2015 FY | -907.99 Thousand AUD | -4.92% |
| 2014 FY | -865.41 Thousand AUD | -121.82% |
| 2013 FY | -390.14 Thousand AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 97.04% |
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | 301.348% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | -14562.729% |
| Biome Australia Limited | 7.66 Million AUD | 80.339% |
| Patrys Limited | 1.39 Million AUD | -8.159% |
| Orthocell Limited | 3.68 Million AUD | 59.118% |
| Imugene Limited | -5.83 Million AUD | 125.821% |
| Noxopharm Limited | -534.81 Thousand AUD | 381.953% |
| PYC Therapeutics Limited | 22.05 Million AUD | 93.164% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 79.77% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 59.381% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | 234.253% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 34.881% |
| CSL Limited | 15.28 Billion AUD | 99.99% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | 5904.361% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | 600.222% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 98.069% |
| Starpharma Holdings Limited | 7.65 Million AUD | 80.307% |
| Nanollose Limited | -348.95 Thousand AUD | 532.127% |
| Memphasys Limited | 1606.00 AUD | -93792.59% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -24.389% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | 1750.936% |
| Amplia Therapeutics Limited | 4.01 Million AUD | 62.403% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | 123.016% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -20.481% |
| Race Oncology Limited | 1.38 Million AUD | -8.49% |
| Nyrada Inc. | -5164.07 AUD | 29300.127% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 99.511% |
| Dimerix Limited | 583.47 Thousand AUD | -158.436% |
| PharmAust Limited | -1641.00 AUD | 91990.006% |
| Immutep Limited | 1.44 Million AUD | -4.433% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 86.895% |
| Alterity Therapeutics Limited | 3.8 Million AUD | 60.37% |
| BTC Health Limited | 16.36 Thousand AUD | -9117.084% |
| Acrux Limited | -1.28 Million AUD | 217.439% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 99.265% |
| Biotron Limited | -40.49 Thousand AUD | 3823.431% |
| Tissue Repair Ltd | 150.51 Thousand AUD | -901.864% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 107.077% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | -227.525% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | -2554.219% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | 511.136% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | 3543.121% |
| Actinogen Medical Limited | 9.93 Million AUD | 84.817% |
| Immuron Limited | 3.33 Million AUD | 54.81% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 41.957% |